Related Experiment Video
Updated: Jul 24, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
Published on: August 28, 2018
Pleiotropy of PCSK9: Functions in Extrahepatic Tissues
Yusuf Ziya Şener1, Lale Tokgözoğlu2
1Cardiology Department, Beypazarı State Hospital, Ankara, Turkey. yzsener@yahoo.com.tr.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) impacts heart, brain, and kidney functions beyond cholesterol metabolism. PCSK9 inhibitors show beneficial or neutral effects on these organs, with no link to new-onset diabetes in real-world data.
Area of Science:
- Cardiovascular Science
- Nephrology
- Neurology
Background:
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) is primarily known for its role in LDL receptor metabolism in the liver.
- Emerging evidence highlights PCSK9's involvement in diverse physiological functions across multiple organs.
Purpose of the Study:
- To review and summarize the extraliver functions of PCSK9.
- To explore the implications of PCSK9's extraliver roles in the context of PCSK9 inhibitor therapy.
Main Methods:
- Literature review of studies investigating PCSK9's functions in non-hepatic tissues.
- Analysis of clinical data regarding the effects of PCSK9 inhibitors on cardiac, renal, and neurological outcomes.
Main Results:
- PCSK9 plays significant roles in cardiac, renal, and neurological systems.
- PCSK9 inhibitors demonstrate beneficial or neutral effects on these organs.
- While experimental studies suggested a link between PCSK9 inhibition and new-onset diabetes, real-world data show no such association.
Conclusions:
- Understanding PCSK9's extraliver functions is crucial for optimizing PCSK9 inhibitor therapy.
- PCSK9 inhibition appears safe and potentially beneficial for cardiovascular, renal, and neurological health.
- PCSK9 may represent a future therapeutic target for conditions like nephrotic syndrome and heart failure.
More Related Videos
Related Concept Videos
Pleiotropy
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Epistasis
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...

